Abstract
The number of patients with cardiac implantable electronic devices (CIEDs) requiring radiation therapy (RT) for cancer treatment is increasing. The purpose of this study is to estimate the prevalence, possible predictors, and clinical impact of RT-related CIEDs malfunctions. We retrospectively reviewed the medical records of all pacemaker (PM)/implantable cardioverter-defibrillator (ICD) patients who underwent RT in the last 14 years. One hundred and twenty-seven patients who underwent 150 separate RT courses were analysed (99 with a PM and 27 with an ICD). Of note, 21/127 (16.6%) patients were PM-dependent. Neutron-producing RT was used in 37/139 (26.6%) courses, whereas non-neutron-producing RT was used in 102/139 (73.4%) courses. The cumulative dose (Dmax) delivered to the CIED exceeded 5 Gy only in 2/132 (1.5%) cases. Device malfunctions were observed in 3/150 (2%) RT courses, but none was life-threatening or led to a major clinical event and all were resolved by CIED reprogramming. In all cases, the Dmax delivered to the CIED was < 2 Gy. Two malfunctions occurred in the 37 patients treated with neutron-producing RT (5.4%), and 1 malfunction occurred in the 102 patients treated with non-neutron-producing RT (1%) (p = 0.17). Device relocation from the RT field was performed in 2/127 (1.6%) patients. RT in patients with CIED is substantially safe if performed in an appropriately organized environment, with uncommon CIEDs malfunctions and no major clinical events. Neutron-producing energies, rather than Dmax, seem to increase the risk of malfunctions. Device interrogation on a regular basis is advised to promptly manage CIED malfunctions.
Similar content being viewed by others
References
Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, Delaney GP (2014) Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 112:140–144. https://doi.org/10.1016/j.radonc.2014.03.024
Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13:790–801. https://doi.org/10.1016/S1470-2045(12)70211-5
Zhan C, Baine WB, Sedrakyan A, Steiner C (2008) Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 23(Suppl 1):13–19. https://doi.org/10.1007/s11606-007-0392-0
Lenarczyk R, Potpara TS, Haugaa KH, Deharo JC, Hernandez-Madrid A, Del Carmen Exposito Pineda M, Kiliszek M, Dagres N (2017) Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey. Europace 19:1579–1584. https://doi.org/10.1093/europace/eux195
Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, Dickfeld TL, Froelich JW, Grant J, Hayes DL, Heidbuchel H, Idriss SF, Kanal E, Lampert R, Machado CE, Mandrola JM, Nazarian S, Patton KK, Rozner MA, Russo RJ, Shen WK, Shinbane JS, Teo WS, Uribe W, Verma A, Wilkoff BL, Woodard PK (2017) 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm 14:e97–e153. https://doi.org/10.1016/j.hrthm.2017.04.025
Zecchin M, Severgnini M, Fiorentino A, Malavasi VL, Menegotti L, Alongi F, Catanzariti D, Jereczek-Fossa BA, Stasi M, Russi E, Boriani G (2018) Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). Int J Cardiol 255:175–183. https://doi.org/10.1016/j.ijcard.2017.12.061
Hurkmans CW, Knegjens JL, Oei BS, Maas AJ, Uiterwaal GJ, van der Borden AJ, Ploegmakers MM, van Erven L, Dutch Society of Radiotherapy and Oncology (NVRO) (2012) Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol 7:198. https://doi.org/10.1186/1748-717X-7-198
Gauter-Fleckenstein B, Israel CW, Dorenkamp M, Dunst J, Roser M, Schimpf R, Steil V, Schäfer J, Höller U, Wenz F, DEGRO/DGK (2015) DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol 191:393–404. https://doi.org/10.1007/s00066-015-0817-3
Zecchin M, Artico J, Morea G, Severgnini M, Bianco E, De Luca A, Fantasia AZ, Salvatore L, Milan V, Lucarelli M, Dissegna R, Cannatà A, Sinagra G (2018) Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses. J Cardiovasc Med (Hagerstown) 19:155–160. https://doi.org/10.2459/JCM.0000000000000623
Bagur R, Chamula M, Brouillard É, Lavoie C, Nombela-Franco L, Julien AS, Archambault L, Varfalvy N, Gaudreault V, Joncas SX, Israeli Z, Parviz Y, Mamas MA, Lavi S (2017) Radiotherapy-induced cardiac implantable electronic device dysfunction in patients with cancer. Am J Cardiol 119:284–289. https://doi.org/10.1016/j.amjcard.2016.09.036
https://www.salute.gov.it/imgs/C_17_AvvisiSicurezza_1195_azione_itemAzione_0_files_itemFiles_0_fileAzione.pdf. Accessed 15 Mar 2019
Makkar A, Prisciandaro J, Agarwal S, Lusk M, Horwood L, Moran J, Fox C, Hayman JA, Ghanbari H, Roberts B, Belardi D, Latchamsetty R, Crawford T, Good E, Jongnarangsin K, Bogun F, Chugh A, Oral H, Morady F, Pelosi F Jr (2012) Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function. Heart Rhythm 9:1964–1968. https://doi.org/10.1016/j.hrthm.2012.08.018
Zaremba T, Jakobsen AR, Søgaard M, Thøgersen AM, Johansen MB, Madsen LB, Riahi S (2015) Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol 38:343–356. https://doi.org/10.1111/pace.12572
Brambatti M, Mathew R, Strang B, Dean J, Goyal A, Hayward JE, Long L, DeMeis P, Smoke M, Connolly SJ, Morillo CA, Amit G, Capucci A, Healey JS (2015) Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. Heart Rhythm 12:2148–2154. https://doi.org/10.1016/j.hrthm.2015.06.003
Bravo-Jaimes K, Samala V, Fernandez G, Moravan MJ, Dhakal S, Shah AH, Messing S, Singh K, Aktas MK (2018) CIED malfunction in patients receiving radiation is a rare event that could be detected by remote monitoring. J Cardiovasc Electrophysiol 29:1268–1275. https://doi.org/10.1111/jce.13659
Brouillard É, Chamula M, Lavoie C, Varfalvy N, Archambault L (2019) Radiation therapy-induced dysfunction in cardiovascular implantable electronic devices. Pract Radiat Oncol. 9:266–273. https://doi.org/10.1016/j.prro.2019.03.003
Yeung C, Hazim B, Campbell D, Gooding J, Li SX, Tam HK, Hopman WM, Chacko S, Redfearn DP, Simpson C, Abdollah H, Baranchuk A (2019) Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience. J Interv Card Electrophysiol. 55:333–341. https://doi.org/10.1007/s10840-018-0506-0
Kapa S, Fong L, Blackwell CR, Herman MG, Schomberg PJ, Hayes DL (2008) Effects of scatter radiation on ICD and CRT function. Pacing Clin Electrophysiol 31:727–732. https://doi.org/10.1111/j.1540-8159.2008.01077.x
Soejima T, Yoden E, Nishimura Y, Ono S, Yoshida A, Fukuda H, Fukuhara N, Sasaki R, Tsujino K, Norihisa Y (2011) Radiation therapy in patients with implanted cardiac pacemakers and implantable cardioverter defibrillators: a prospective survey in Japan. J Radiat Res 52:516–521. https://doi.org/10.1269/jrr.10143
Riva G, Alessandro O, Spoto R, Ferrari A, Garibaldi C, Cattani F, Luraschi R, Rondi E, Colombo N, Giovenzana FLF, Cipolla CM, Winnicki M, Persiani M, Castelluccia F, Fiore MS, Orecchia R, Jereczek-Fossa BA (2018) Radiotherapy in patients with cardiac implantable electronic devices: clinical and dosimetric aspects. Med Oncol 35:73. https://doi.org/10.1007/s12032-018-1126-3
Gelblum DY, Amols H (2009) Implanted cardiac defibrillator care in radiation oncology patient population. Int J Radiat Oncol Biol Phys 73:1525–1531. https://doi.org/10.1016/j.ijrobp.2008.06.1903
Gossman MS, Wilkinson JD, Mallick A (2014) Treatment approach, delivery, and follow-up evaluation for cardiac rhythm disease management patients receiving radiation therapy: retrospective physician surveys including chart reviews at numerous centers. Med Dosim 39:320–324. https://doi.org/10.1016/j.meddos.2014.05.005
Grant JD, Jensen GL, Tang C, Pollard JM, Kry SF, Krishnan S, Dougherty AH, Gomez DR, Rozner MA (2015) Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol 1:624–632. https://doi.org/10.1001/jamaoncol.2015.1787
Elders J, Kunze-Busch M, Smeenk RJ, Smeets JL (2013) High incidence of implantable cardioverter defibrillator malfunctions during radiation therapy: neutrons as a probable cause of soft errors. Europace 15:60–65. https://doi.org/10.1093/europace/eus197
Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH (2013) Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys 87:570–575. https://doi.org/10.1093/europace/eus197
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Professor Boriani has received small speaker’s fees from Medtronic, Boston, Boehringer, and Bayer, outside of the submitted work. The other authors reported no conflict of interest.
Human and animal rights statement
Protocol approved by the Ethical Committee (No. 750/2018/OSS/AOUMO). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Due to retrospective design of the study, no informed consent needed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Malavasi, V.L., De Marco, G., Imberti, J.F. et al. Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients. Intern Emerg Med 15, 967–973 (2020). https://doi.org/10.1007/s11739-019-02240-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02240-y